89 related articles for article (PubMed ID: 7558042)
1. Coexisting amplifications of the chromosome 1p32 genes (PTPRF and MYCL1) encoding protein tyrosine phosphatase LAR and L-myc in a small cell lung cancer line.
Harder KW; Saw J; Miki N; Jirik F
Genomics; 1995 Jun; 27(3):552-3. PubMed ID: 7558042
[No Abstract] [Full Text] [Related]
2. Co-amplification of a novel cyclophilin-like gene (PPIE) with L-myc in small cell lung cancer cell lines.
Kim JO; Nau MM; Allikian KA; Mäkelä TP; Alitalo K; Johnson BE; Kelley MJ
Oncogene; 1998 Aug; 17(8):1019-26. PubMed ID: 9747881
[TBL] [Abstract][Full Text] [Related]
3. myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer.
Johnson BE; Brennan JF; Ihde DC; Gazdar AF
J Natl Cancer Inst Monogr; 1992; (13):39-43. PubMed ID: 1327035
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
Saksela K; Bergh J; Nilsson K
J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069
[TBL] [Abstract][Full Text] [Related]
5. Rearrangement and co-amplification of L-myc and rlf in primary lung cancer.
Mäkelä TP; Shiraishi M; Borrello MG; Sekiya T; Alitalo K
Oncogene; 1992 Mar; 7(3):405-9. PubMed ID: 1312699
[TBL] [Abstract][Full Text] [Related]
6. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
Sato M; Takahashi K; Nagayama K; Arai Y; Ito N; Okada M; Minna JD; Yokota J; Kohno T
Genes Chromosomes Cancer; 2005 Dec; 44(4):405-14. PubMed ID: 16114034
[TBL] [Abstract][Full Text] [Related]
7. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
8. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
[TBL] [Abstract][Full Text] [Related]
9. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
Wang X; Weng LP; Yu Q
Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
[TBL] [Abstract][Full Text] [Related]
11. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines.
Johnson BE; Makuch RW; Simmons AD; Gazdar AF; Burch D; Cashell AW
Cancer Res; 1988 Sep; 48(18):5163-6. PubMed ID: 2842046
[TBL] [Abstract][Full Text] [Related]
12. The gene for leukocyte antigen-related tyrosine phosphatase (LAR) is localized to human chromosome 1p32, a region frequently deleted in tumors of neuroectodermal origin.
Jirik FR; Harder KW; Melhado IG; Anderson LL; Duncan AM
Cytogenet Cell Genet; 1992; 61(4):266-8. PubMed ID: 1486801
[TBL] [Abstract][Full Text] [Related]
13. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
[TBL] [Abstract][Full Text] [Related]
14. High level amplification of 1p32-33 and 2p22-24 in small cell lung carcinomas.
Lui WO; Tanenbaum DM; Larsson C
Int J Oncol; 2001 Sep; 19(3):451-7. PubMed ID: 11494021
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue.
Yang T; Zhang JS; Massa SM; Han X; Longo FM
Mol Carcinog; 1999 Jun; 25(2):139-49. PubMed ID: 10365916
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer.
Dosaka-Akita H; Akie K; Hiroumi H; Kinoshita I; Kawakami Y; Murakami A
Cancer Res; 1995 Apr; 55(7):1559-64. PubMed ID: 7882365
[TBL] [Abstract][Full Text] [Related]
17. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between drug resistance and oncogenes in lung cancer cell lines].
Tanio Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():42-7. PubMed ID: 1339094
[TBL] [Abstract][Full Text] [Related]
19. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV
Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866
[TBL] [Abstract][Full Text] [Related]
20. Oncogenes and a specific chromosomal abnormality associated with small-cell lung cancers.
Taya Y
Jpn J Clin Oncol; 1986 Sep; 16(3):199-202. PubMed ID: 3022029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
